BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$231M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$145M |
| 3 |
Liberty Broadband Class C
LBRDK
|
+$63M |
| 4 |
Pinterest
PINS
|
+$53.4M |
| 5 |
Prologis
PLD
|
+$50.8M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$4.18B |
| 2 |
Apple
AAPL
|
+$1.93B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.78B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Microsoft
MSFT
|
+$1.2B |
Sector Composition
| 1 | Technology | 16.91% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Financials | 12.2% |
| 4 | Healthcare | 8.11% |
| 5 | Communication Services | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Civista Bancshares
CIVB
$401M
| $72.5K | ﹤0.01% |
4,136
+289
| +8% | +$5.07K |
|
2602
The Joint Corp
JYNT
$155M
| $72.5K | ﹤0.01% |
2,760
-529
| -16% | -$13.9K |
|
2603
Rigel Pharmaceuticals
RIGL
$672M
| $72.2K | ﹤0.01% |
2,064
-2,154
| -51% | -$75.4K |
|
2604
Mesa Air Group
MESA
$57.8M
| $72.1K | ﹤0.01% |
10,778
-385
| -3% | -$2.58K |
|
2605
ANI Pharmaceuticals
ANIP
$2.14B
| $72.1K | ﹤0.01% |
2,482
+48
| +2% | +$1.39K |
|
|
QTNT
2606
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $72K | ﹤0.01% |
346
+9
| +3% | +$1.87K |
|
2607
Oil-Dri
ODC
$962M
| $71.8K | ﹤0.01% |
4,216
+1,668
| +65% | +$28.4K |
|
|
BELFB
2608
Bel Fuse Class B
BELFB
$1.82B
| $71.4K | ﹤0.01% |
4,751
+2,467
| +108% | +$37.1K |
|
2609
First Bancorp
FNLC
$300M
| $71.4K | ﹤0.01% |
2,810
+258
| +10% | +$6.55K |
|
2610
KT
KT
$9.47B
| $71.3K | ﹤0.01% |
6,472
| – | – |
|
2611
Fidelity D&D Bancorp
FDBC
$268M
| $71.2K | ﹤0.01% |
1,106
-63
| -5% | -$4.06K |
|
2612
Hackett Group
HCKT
$579M
| $71.2K | ﹤0.01% |
4,946
-1,015
| -17% | -$14.6K |
|
|
CAMP
2613
DELISTED
CalAmp Corp.
CAMP
| $71.1K | ﹤0.01% |
312
-55
| -15% | -$12.5K |
|
2614
Primis Financial Corp
FRST
$269M
| $70.9K | ﹤0.01% |
5,858
+927
| +19% | +$11.2K |
|
2615
UFP Technologies
UFPT
$1.51B
| $70.9K | ﹤0.01% |
1,521
+19
| +1% | +$885 |
|
2616
Nutrien
NTR
$27.8B
| $70.6K | ﹤0.01% |
1,466
-5,034
| -77% | -$242K |
|
|
CURO
2617
DELISTED
CURO Group Holdings Corp.
CURO
| $70.5K | ﹤0.01% |
4,918
-79
| -2% | -$1.13K |
|
2618
Citizens & Northern Corp
CZNC
$309M
| $70K | ﹤0.01% |
3,529
+293
| +9% | +$5.81K |
|
2619
Alaunos Therapeutics
TCRT
$5.12M
| $69.9K | ﹤0.01% |
185
-139
| -43% | -$52.5K |
|
2620
Preformed Line Products
PLPC
$967M
| $69.9K | ﹤0.01% |
1,021
+302
| +42% | +$20.7K |
|
2621
Verastem
VSTM
$577M
| $69.8K | ﹤0.01% |
2,731
-583
| -18% | -$14.9K |
|
2622
Citizens
CIA
$273M
| $69.7K | ﹤0.01% |
12,167
+616
| +5% | +$3.53K |
|
2623
RBB Bancorp
RBB
$332M
| $69.4K | ﹤0.01% |
4,513
+448
| +11% | +$6.89K |
|
2624
Spyre Therapeutics
SYRE
$963M
| $69.3K | ﹤0.01% |
352
-46
| -12% | -$9.06K |
|
2625
DHI Group
DHX
$139M
| $69.3K | ﹤0.01% |
31,194
+20,481
| +191% | +$45.5K |
|